Innate Pharma
IPHA
#8408
Rank
A$0.26 B
Marketcap
$3.03
Share price
-4.19%
Change (1 day)
-20.24%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -A$13.85 Million

According to Innate Pharma 's latest financial reports the company's current earnings are A$57.37 Million. In 2023 the company made an earning of -A$13.85 Million, an increase over its 2022 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-A$13.85 Million-86.54%
2022-A$0.11 Billion20.74%
2021-A$85.19 Million4951.09%
2020-A$1.69 Million-111.57%
2019A$14.57 M183.46%
2018A$5.14 M-105.4%
2017-A$95.3 Million-523.25%
2016A$22.51 M-285.64%
2015-A$12.13 Million-69.31%
2014-A$39.53 Million498.29%
2013-A$6.61 Million-5.62%
2012-A$7 Million-53.32%
2011-A$15 Million-50.1%
2010-A$30.05 Million-13.3%
2009-A$34.66 Million26.36%
2008-A$27.43 Million27.35%
2007-A$21.54 Million63.33%
2006-A$13.19 Million9.81%
2005-A$12.01 Million